Literature DB >> 8518789

Apo-dystrophin-3: a 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site.

J M Tinsley1, D J Blake, K E Davies.   

Abstract

The molecular defect in Duchenne muscular dystrophy is well established as being due to mutations at Xp21 which disrupt the normal synthesis of the 14kb dystrophin mRNA. More recently, several groups have identified a 4.8kb transcript from this locus which shares exons with the carboxy-terminal region of the dystrophin gene. In this paper we present evidence for an additional 2.2kb mRNA transcript. The 5' untranslated region and first 7 amino acids are identical to that published for the 4.8kb transcript. The position of the translational stop codon and 3' untranslated region is similar to that previously described as the truncated fetal dystrophin isoform. This 2.2kb mRNA has a similar tissue distribution to that described for the 4.8kb mRNA but unlike the other transcripts from the DMD locus, the 2.2kb mRNA is expressed in early development. The relevance of this transcript in the clinical expression of muscular dystrophy and developmental delay is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518789     DOI: 10.1093/hmg/2.5.521

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

Review 1.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

Review 2.  Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy.

Authors:  Perry B Shieh
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 3.  Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene.

Authors:  Ramin Tadayoni; Alvaro Rendon; L E Soria-Jasso; Bulmaro Cisneros
Journal:  Mol Neurobiol       Date:  2011-11-22       Impact factor: 5.590

Review 4.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

5.  Dystrophin Dp71 Isoforms Are Differentially Expressed in the Mouse Brain and Retina: Report of New Alternative Splicing and a Novel Nomenclature for Dp71 Isoforms.

Authors:  Jorge Aragón; Mayram González-Reyes; José Romo-Yáñez; Ophélie Vacca; Guadalupe Aguilar-González; Alvaro Rendón; Cyrille Vaillend; Cecilia Montañez
Journal:  Mol Neurobiol       Date:  2017-01-27       Impact factor: 5.590

6.  Identification of Dp71 Isoforms Expressed in PC12 Cells: Subcellular Localization and Colocalization with β-Dystroglycan and α1-Syntrophin.

Authors:  Jorge Aragón; Alejandro Martínez-Herrera; José Romo-Yáñez; Víctor Ceja; Coztli Azotla-Vilchis; Lourdes Siqueiros-Márquez; Gabriela Soid-Raggi; Alma Herrera-Salazar; Cecilia Montañez
Journal:  J Mol Neurosci       Date:  2015-09-28       Impact factor: 3.444

7.  Re-evaluation of the distributions of dystrophin and utrophin in sciatic nerve.

Authors:  E Fabbrizio; J Latouche; F Rivier; G Hugon; D Mornet
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

8.  The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain.

Authors:  Takenori Tozawa; Kyoko Itoh; Takeshi Yaoi; So Tando; Masafumi Umekage; Hongmei Dai; Hajime Hosoi; Shinji Fushiki
Journal:  Mol Neurobiol       Date:  2012-01-19       Impact factor: 5.590

9.  Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain.

Authors:  G E Crawford; J A Faulkner; R H Crosbie; K P Campbell; S C Froehner; J S Chamberlain
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

10.  Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.

Authors:  Yusuke Echigoya; Joshua Lee; Merryl Rodrigues; Tetsuya Nagata; Jun Tanihata; Ashkan Nozohourmehrabad; Dharminder Panesar; Bailey Miskew; Yoshitsugu Aoki; Toshifumi Yokota
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.